Tags : Compassionate Use

COVID-19 Regulatory

EMA’s CHMP Recommends Compassionate Use of Gilead’s Remdesivir for COVID-19

Shots: On Apr 02, 2020, EMA’s CHMP has recommended Gilead’s Remdesivir to be used for treating COVID-19 in compassionate use programmes in the EU Compassionate use programmes are intended to provide patients access to therapies that are under development and have not yet received a marketing authorization. The CHMP encourages Gilead to make remdesivir available […]Read More